-
-
-
-
-
-
-
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
-
-
-
-
-
-
-
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
-
-
-
-
-
-
Achieve Life Sciences promotes Dr. Mark Rubinstein to chief medical officer
-
-
-
-
-
-
-
Achieve Life Sciences submits 120-day safety update to FDA for smoking drug
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
-
-
-
-
-
-
Achieve Life Sciences names Dr. Mark Rubinstein interim CMO
-
15,481 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

